| 1 |
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.Nat Genet. 2012 Oct;44(10):1090-7. doi: 10.1038/ng.2411. Epub 2012 Sep 9.
|
| 2 |
ABL regulation by AXL promotes cisplatin resistance in esophageal cancer.Cancer Res. 2013 Jan 1;73(1):331-40. doi: 10.1158/0008-5472.CAN-12-3151. Epub 2012 Nov 1.
|
| 3 |
Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci. 2011 Jun;102(6):1128-36.
|
| 4 |
Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo.Mol Med Rep. 2015 Jul;12(1):1465-72. doi: 10.3892/mmr.2015.3517. Epub 2015 Mar 20.
|
| 5 |
lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR?45/p70S6K1 and p53 pathway.Int J Oncol. 2020 Jan;56(1):327-336. doi: 10.3892/ijo.2019.4929. Epub 2019 Dec 2.
|
| 6 |
Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo.Oncol Lett. 2019 Jun;17(6):5012-5022. doi: 10.3892/ol.2019.10160. Epub 2019 Mar 19.
|
| 7 |
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity.Cancer Lett. 2004 Sep 30;213(2):173-9. doi: 10.1016/j.canlet.2004.04.016.
|
| 8 |
Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.Cell Mol Life Sci. 2019 Dec;76(24):5027-5039. doi: 10.1007/s00018-019-03159-5. Epub 2019 Jun 12.
|
| 9 |
Amplification and expression of the human cyclin D gene in esophageal cancer.Cancer Res. 1992 May 15;52(10):2980-3.
|
| 10 |
Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.Eur J Cancer. 2006 May;42(7):972-80. doi: 10.1016/j.ejca.2006.01.021. Epub 2006 Mar 27.
|
| 11 |
Primary impact of Gli1 on radioresistance in esophageal cancer.Oncol Lett. 2019 Nov;18(5):4825-4833. doi: 10.3892/ol.2019.10837. Epub 2019 Sep 10.
|
| 12 |
Identification of recurrent fusion genes across multiple cancer types.Sci Rep. 2019 Jan 31;9(1):1074. doi: 10.1038/s41598-019-38550-6.
|
| 13 |
Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.Ann Oncol. 2008 Mar;19(3):527-32. doi: 10.1093/annonc/mdm469. Epub 2007 Oct 26.
|
| 14 |
A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.Oncotarget. 2016 May 24;7(21):31137-52. doi: 10.18632/oncotarget.9082.
|
| 15 |
Grim-19 expressed by recombinant adenovirus for esophageal neoplasm target therapy.Mol Med Rep. 2018 May;17(5):6667-6674. doi: 10.3892/mmr.2018.8638. Epub 2018 Feb 27.
|
| 16 |
Effect and mechanism of PAR-2 on the proliferation of esophageal cancer cells.Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4688-4696.
|
| 17 |
Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer.Oncogene. 2002 Jul 25;21(32):5024-30. doi: 10.1038/sj.onc.1205627.
|
| 18 |
Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.Cancer Sci. 2019 May;110(5):1552-1563. doi: 10.1111/cas.13986. Epub 2019 Apr 15.
|
| 19 |
Novel cancer suppressor gene for esophageal cancer: manganese superoxide dismutase.Dis Esophagus. 2011 Jul;24(5):346-53. doi: 10.1111/j.1442-2050.2010.01149.x. Epub 2010 Dec 10.
|
| 20 |
B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu).Mutat Res. 1993 Oct;289(2):187-95. doi: 10.1016/0027-5107(93)90069-r.
|
| 21 |
Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.Anticancer Res. 1998 May-Jun;18(3A):1465-72.
|
| 22 |
PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.Ann Surg. 2019 Mar;269(3):471-478. doi: 10.1097/SLA.0000000000002616.
|
| 23 |
The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.World J Surg. 2018 Mar;42(3):749-757. doi: 10.1007/s00268-017-4203-4.
|
| 24 |
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.J Clin Oncol. 1993 Oct;11(10):2010-20. doi: 10.1200/JCO.1993.11.10.2010.
|
| 25 |
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.Ann Oncol. 2019 Nov 1;30(11):1821-1830. doi: 10.1093/annonc/mdz291.
|
| 26 |
MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.J Gene Med. 2019 May;21(5):e3086. doi: 10.1002/jgm.3086. Epub 2019 Apr 8.
|
| 27 |
PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.World J Surg Oncol. 2017 May 25;15(1):105. doi: 10.1186/s12957-017-1172-x.
|
| 28 |
ABCB1 Is Upregulated in Acquisition of Taxane Resistance: Lessons from Esophageal Squamous Cell Carcinoma Cell Lines.Tohoku J Exp Med. 2016 Dec;240(4):295-301. doi: 10.1620/tjem.240.295.
|
| 29 |
Multiple ADH genes are associated with upper aerodigestive cancers.Nat Genet. 2008 Jun;40(6):707-9. doi: 10.1038/ng.151. Epub 2008 May 25.
|
| 30 |
Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 2001 Jun 15;61(12):4879-84.
|
| 31 |
Regulation of OLC1 protein expression by the anaphase-promoting complex.Oncol Lett. 2019 Mar;17(3):2639-2646. doi: 10.3892/ol.2019.9881. Epub 2019 Jan 2.
|
| 32 |
Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.PLoS One. 2013 Dec 13;8(12):e82790. doi: 10.1371/journal.pone.0082790. eCollection 2013.
|
| 33 |
Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs. Cancer Biol Ther. 2006 Apr;5(4):380-5. doi: 10.4161/cbt.5.4.2477. Epub 2006 Apr 4.
|
| 34 |
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.Clin Cancer Res. 2007 Jul 15;13(14):4146-53. doi: 10.1158/1078-0432.CCR-06-3063.
|
| 35 |
Dual effects of an anti-CD147 antibody for Esophageal cancer therapy.Cancer Biol Ther. 2019;20(12):1443-1452. doi: 10.1080/15384047.2019.1647052. Epub 2019 Aug 14.
|
| 36 |
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies.Hum Mol Genet. 2012 May 1;21(9):2132-41. doi: 10.1093/hmg/dds029. Epub 2012 Feb 8.
|
| 37 |
Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.Oncol Rep. 2019 Mar;41(3):1960-1970. doi: 10.3892/or.2018.6923. Epub 2018 Dec 10.
|
| 38 |
The prognostic significance of high/positive expression of cyclin B1 in patients with three common digestive cancers: a systematic review and meta-analysis.Oncotarget. 2017 Sep 26;8(56):96373-96383. doi: 10.18632/oncotarget.21273. eCollection 2017 Nov 10.
|
| 39 |
Correlation between the protein expression levels of A-kinase anchor protein95, p-retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues.Asia Pac J Clin Oncol. 2019 Oct;15(5):e162-e166. doi: 10.1111/ajco.13146. Epub 2019 Apr 16.
|
| 40 |
Expression of immune checkpoints in T cells of esophageal cancer patients.Oncotarget. 2016 Sep 27;7(39):63669-63678. doi: 10.18632/oncotarget.11611.
|
| 41 |
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.Oncotarget. 2018 May 4;9(34):23482-23493. doi: 10.18632/oncotarget.25235. eCollection 2018 May 4.
|
| 42 |
Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.Clin Cancer Res. 2016 Mar 1;22(5):1243-55. doi: 10.1158/1078-0432.CCR-15-1196. Epub 2015 Oct 16.
|
| 43 |
Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis.Surg Oncol. 2017 Dec;26(4):460-472. doi: 10.1016/j.suronc.2017.09.003. Epub 2017 Sep 14.
|
| 44 |
Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.Mol Carcinog. 2020 Jan;59(1):32-44. doi: 10.1002/mc.23126. Epub 2019 Oct 16.
|
| 45 |
DpdtbA-Induced Growth Inhibition in Human Esophageal Cancer Cells Involved Inactivation of the p53/EGFR/AKT Pathway.Oxid Med Cell Longev. 2019 Jul 1;2019:5414670. doi: 10.1155/2019/5414670. eCollection 2019.
|
| 46 |
Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.Cancer Genet Cytogenet. 2002 Aug;137(1):1-7. doi: 10.1016/s0165-4608(02)00549-6.
|
| 47 |
CHST15 promotes the proliferation of TE? cells via multiple pathways in esophageal cancer.Oncol Rep. 2020 Jan;43(1):75-86. doi: 10.3892/or.2019.7395. Epub 2019 Oct 30.
|
| 48 |
VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.Cytokine. 2011 Jul;55(1):8-17. doi: 10.1016/j.cyto.2011.03.008. Epub 2011 Apr 11.
|
| 49 |
Variants in COL6A3 gene influence susceptibility to esophageal cancer in the Chinese population.Cancer Genet. 2019 Oct;238:23-30. doi: 10.1016/j.cancergen.2019.07.003. Epub 2019 Jul 13.
|
| 50 |
Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.Kaohsiung J Med Sci. 2020 Jan;36(1):54-61. doi: 10.1002/kjm2.12129. Epub 2019 Sep 12.
|
| 51 |
Comparative proteomic analysis of esophageal squamous cell carcinoma.Proteomics. 2005 Jul;5(11):2960-71. doi: 10.1002/pmic.200401175.
|
| 52 |
Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis.Ther Adv Med Oncol. 2017 Jan;9(1):13-21. doi: 10.1177/1758834016668682. Epub 2016 Sep 18.
|
| 53 |
Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.Nat Genet. 2011 Jun 5;43(7):679-84. doi: 10.1038/ng.849.
|
| 54 |
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.Int J Cancer. 2006 Jan 1;118(1):123-8. doi: 10.1002/ijc.21219.
|
| 55 |
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16.
|
| 56 |
Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer.Mol Med Rep. 2015 Nov;12(5):7419-24. doi: 10.3892/mmr.2015.4410. Epub 2015 Oct 1.
|
| 57 |
Considering temozolomide as a novel potential treatment for esophageal cancer. Cancer. 2011 May 1;117(9):2004-16. doi: 10.1002/cncr.25687. Epub 2010 Nov 8.
|
| 58 |
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.Neoplasia. 2011 Apr;13(4):386-92. doi: 10.1593/neo.101722.
|
| 59 |
Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a high-incidence area of northern China.Oncol Lett. 2019 Aug;18(2):1267-1277. doi: 10.3892/ol.2019.10455. Epub 2019 Jun 7.
|
| 60 |
Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study.BMC Gastroenterol. 2016 Jul 30;16(1):85. doi: 10.1186/s12876-016-0499-z.
|
| 61 |
Translational research on Barrett's esophagus.Ann N Y Acad Sci. 2014 Sep;1325:170-86. doi: 10.1111/nyas.12531.
|
| 62 |
Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.Oncol Res. 2017 Jul 5;25(6):887-895. doi: 10.3727/096504016X14817158982636. Epub 2016 Dec 15.
|
| 63 |
Indomethacin induces apoptosis in the EC109 esophageal cancer cell line by releasing second mitochondria-derived activator of caspase and activating caspase-3.Mol Med Rep. 2015 Jun;11(6):4694-700. doi: 10.3892/mmr.2015.3331. Epub 2015 Feb 11.
|
| 64 |
Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.FASEB J. 2019 Feb;33(2):1972-1988. doi: 10.1096/fj.201800759R. Epub 2018 Sep 18.
|
| 65 |
Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma.Acta Histochem. 2014 Jun;116(5):803-9. doi: 10.1016/j.acthis.2014.01.010. Epub 2014 Mar 12.
|
| 66 |
Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection.Curr Med Sci. 2019 Jun;39(3):385-390. doi: 10.1007/s11596-019-2047-x. Epub 2019 Jun 17.
|
| 67 |
Upregulated expression and activation of membraneassociated proteases in esophageal squamous cell carcinoma.Oncol Rep. 2014 Jun;31(6):2820-6. doi: 10.3892/or.2014.3162. Epub 2014 Apr 29.
|
| 68 |
Gproteincoupled receptor120 regulates the development and progression of human esophageal cancer.Oncol Rep. 2018 Aug;40(2):1147-1155. doi: 10.3892/or.2018.6470. Epub 2018 May 31.
|
| 69 |
Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells.Int J Oncol. 2007 Oct;31(4):721-8.
|
| 70 |
FOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expression.Cell Death Dis. 2017 Jul 20;8(7):e2946. doi: 10.1038/cddis.2017.340.
|
| 71 |
Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/-catenin and PI3K/AKT signaling pathways.J Cell Physiol. 2019 Nov;234(11):20469-20484. doi: 10.1002/jcp.28648. Epub 2019 Apr 15.
|
| 72 |
Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.Clin Exp Metastasis. 2013 Dec;30(8):977-92. doi: 10.1007/s10585-013-9597-2. Epub 2013 Jun 21.
|
| 73 |
Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer. 2008 Jan 29;98(2):410-7. doi: 10.1038/sj.bjc.6604124. Epub 2008 Jan 22.
|
| 74 |
Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.BMC Cancer. 2011 Feb 25;11:86. doi: 10.1186/1471-2407-11-86.
|
| 75 |
Expression and significance of GRHL2 in esophageal cancer.Onco Targets Ther. 2017 Apr 7;10:2025-2031. doi: 10.2147/OTT.S128294. eCollection 2017.
|
| 76 |
Association between glutathione S-transferases P1 Ile105Val polymorphism and susceptibility to esophageal cancer: evidence from 20 case-control studies.Mol Biol Rep. 2015 Feb;42(2):399-408. doi: 10.1007/s11033-014-3781-6. Epub 2014 Oct 4.
|
| 77 |
HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.Cancer Res. 2009 Jun 15;69(12):4969-73. doi: 10.1158/0008-5472.CAN-08-4546. Epub 2009 Jun 2.
|
| 78 |
Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.Clin Cancer Res. 2005 Nov 15;11(22):7995-8005. doi: 10.1158/1078-0432.CCR-05-1103.
|
| 79 |
Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.Cancer Sci. 2019 Jun;110(6):1863-1871. doi: 10.1111/cas.14028. Epub 2019 May 20.
|
| 80 |
Interleukin 10 rs1800872 T>G polymorphism was associated with an increased risk of esophageal cancer in a Chinese population.Asian Pac J Cancer Prev. 2013;14(6):3443-7. doi: 10.7314/apjcp.2013.14.6.3443.
|
| 81 |
IL-15 receptor alpha rs2228059 A>C polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.Mol Biol Rep. 2014;41(4):1951-7. doi: 10.1007/s11033-014-3042-8. Epub 2014 Jan 28.
|
| 82 |
IL1R2 Polymorphisms are Associated with Increased Risk of Esophageal Cancer.Curr Mol Med. 2020;20(5):379-387. doi: 10.2174/1566524019666191025091204.
|
| 83 |
Rs1884444 variant in IL23R gene is associated with a decreased risk in esophageal cancer in Chinese population.Mol Carcinog. 2019 Oct;58(10):1822-1831. doi: 10.1002/mc.23069. Epub 2019 Jun 13.
|
| 84 |
Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5.Cell Physiol Biochem. 2015;35(2):740-54. doi: 10.1159/000369734. Epub 2015 Jan 30.
|
| 85 |
Integrin 6 promotes esophageal cancer metastasis and is targeted by miR-92b.Oncotarget. 2017 Jan 24;8(4):6681-6690. doi: 10.18632/oncotarget.14259.
|
| 86 |
Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.Am J Cancer Res. 2017 Jan 1;7(1):115-124. eCollection 2017.
|
| 87 |
Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.Int J Cancer. 2019 Feb 15;144(4):828-840. doi: 10.1002/ijc.31953. Epub 2018 Dec 3.
|
| 88 |
MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.Dig Liver Dis. 2019 Jan;51(1):149-156. doi: 10.1016/j.dld.2018.07.017. Epub 2018 Aug 27.
|
| 89 |
Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.J Exp Clin Cancer Res. 2017 Nov 16;36(1):161. doi: 10.1186/s13046-017-0622-1.
|
| 90 |
Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis.Oncol Lett. 2018 Jan;15(1):1229-1235. doi: 10.3892/ol.2017.7433. Epub 2017 Nov 16.
|
| 91 |
LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.Cancer Res. 2019 Oct 1;79(19):4951-4964. doi: 10.1158/0008-5472.CAN-19-0860. Epub 2019 Aug 13.
|
| 92 |
Polymorphic variation of the ARP gene on 3p21 in Japanese esophageal cancer patients.Oncol Rep. 2000 May-Jun;7(3):591-3. doi: 10.3892/or.7.3.591.
|
| 93 |
Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).Oncotarget. 2016 Feb 23;7(8):8756-70. doi: 10.18632/oncotarget.6752.
|
| 94 |
Prognostic significance of TPX2 and NIBP in esophageal cancer.Oncol Lett. 2019 Oct;18(4):4221-4229. doi: 10.3892/ol.2019.10747. Epub 2019 Aug 16.
|
| 95 |
MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas.J Cancer. 2018 Jan 1;9(3):460-468. doi: 10.7150/jca.22310. eCollection 2018.
|
| 96 |
MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.Oncol Rep. 2017 Jun;37(6):3590-3596. doi: 10.3892/or.2017.5614. Epub 2017 May 2.
|
| 97 |
Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.Cancer Sci. 2018 Nov;109(11):3393-3402. doi: 10.1111/cas.13785. Epub 2018 Sep 22.
|
| 98 |
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.Acta Biochim Pol. 2017;64(2):295-299. doi: 10.18388/abp.2016_1408. Epub 2017 May 15.
|
| 99 |
Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis.PLoS One. 2017 Jun 1;12(6):e0176431. doi: 10.1371/journal.pone.0176431. eCollection 2017.
|
| 100 |
Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.Adv Med Sci. 2018 Sep;63(2):296-300. doi: 10.1016/j.advms.2018.04.002. Epub 2018 May 24.
|
| 101 |
Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients.Cancer Cell Int. 2019 Apr 23;19:106. doi: 10.1186/s12935-019-0824-z. eCollection 2019.
|
| 102 |
Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized Therapy.J Nucl Med. 2017 Feb;58(2):266-275. doi: 10.2967/jnumed.116.176313. Epub 2016 Sep 15.
|
| 103 |
Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis.Mol Carcinog. 2004 Aug;40(4):232-40. doi: 10.1002/mc.20035.
|
| 104 |
"NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".Nutr Cancer. 2018 May-Jun;70(4):557-568. doi: 10.1080/01635581.2018.1460674. Epub 2018 Apr 13.
|
| 105 |
Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.FASEB J. 2018 Jan;32(1):404-416. doi: 10.1096/fj.201700227RRR. Epub 2017 Sep 19.
|
| 106 |
MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.Oncotarget. 2018 Jun 19;9(47):28391-28407. doi: 10.18632/oncotarget.25375. eCollection 2018 Jun 19.
|
| 107 |
CircRAD23B facilitates proliferation and invasion of esophageal cancer cells by sponging miR-5095.Biochem Biophys Res Commun. 2019 Aug 20;516(2):357-364. doi: 10.1016/j.bbrc.2019.06.044. Epub 2019 Jun 14.
|
| 108 |
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.Int J Mol Sci. 2018 Dec 20;20(1):13. doi: 10.3390/ijms20010013.
|
| 109 |
Long non-coding RNA FAL1 regulated cell proliferation through Akt pathway via targeting PDK1 in esophageal cancer cells.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5214-5222. doi: 10.26355/eurrev_201808_15719.
|
| 110 |
Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.Oncol Rep. 2007 Apr;17(4):753-60.
|
| 111 |
Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.Oncol Rep. 2013 Jul;30(1):304-12. doi: 10.3892/or.2013.2464. Epub 2013 May 14.
|
| 112 |
Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma.Asian Pac J Cancer Prev. 2015;16(3):997-1000. doi: 10.7314/apjcp.2015.16.3.997.
|
| 113 |
The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4'-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth.Cancer Prev Res (Phila). 2017 May;10(5):308-318. doi: 10.1158/1940-6207.CAPR-16-0318. Epub 2017 Mar 21.
|
| 114 |
G648C variant of DNA polymerase sensitizes esophageal cancer to chemotherapy.Tumour Biol. 2016 Feb;37(2):1941-7. doi: 10.1007/s13277-015-3978-x. Epub 2015 Sep 3.
|
| 115 |
Inhibition of atypical protein kinase C induces apoptosis through autophagic degradation of -catenin in esophageal cancer cells.Mol Carcinog. 2014 Jul;53(7):514-25. doi: 10.1002/mc.22003. Epub 2013 Jan 28.
|
| 116 |
Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2014;15(23):10299-306. doi: 10.7314/apjcp.2014.15.23.10299.
|
| 117 |
LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.Mol Biol Rep. 2013 Mar;40(3):2069-75. doi: 10.1007/s11033-012-2138-2. Epub 2013 Jan 3.
|
| 118 |
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol.Carcinogenesis. 2002 Sep;23(9):1531-6. doi: 10.1093/carcin/23.9.1531.
|
| 119 |
Methylationassociated silencing of miR?28 promotes the development of esophageal cancer by targeting COX? in areas with a high incidence of esophageal cancer.Int J Oncol. 2019 Feb;54(2):644-654. doi: 10.3892/ijo.2018.4653. Epub 2018 Dec 4.
|
| 120 |
F-box protein complex FBXL19 regulates TGF1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation.Mol Cancer. 2014 Apr 1;13:76. doi: 10.1186/1476-4598-13-76.
|
| 121 |
DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.Ann Surg Oncol. 2020 Jun;27(6):2090-2101. doi: 10.1245/s10434-019-08043-x. Epub 2019 Nov 20.
|
| 122 |
Epac1, PDE4, and PKC protein expression and their correlation with AKAP95 and Cx43 in esophagus cancer tissues.Thorac Cancer. 2017 Nov;8(6):572-576. doi: 10.1111/1759-7714.12479. Epub 2017 Aug 3.
|
| 123 |
Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-beta2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A.Mol Cancer. 2010 Apr 28;9:93. doi: 10.1186/1476-4598-9-93.
|
| 124 |
RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet. 2012 Feb 10;90(2):340-6. doi: 10.1016/j.ajhg.2011.12.008. Epub 2012 Jan 19.
|
| 125 |
S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.World J Gastroenterol. 2012 Mar 7;18(9):915-22. doi: 10.3748/wjg.v18.i9.915.
|
| 126 |
SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.Oncotarget. 2017 Mar 14;8(11):17771-17784. doi: 10.18632/oncotarget.14849.
|
| 127 |
SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.Cell Physiol Biochem. 2018;48(1):397. doi: 10.1159/000491769. Epub 2018 Aug 2.
|
| 128 |
SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.J Transl Med. 2015 Oct 6;13:321. doi: 10.1186/s12967-015-0681-z.
|
| 129 |
Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.Cancer Sci. 2016 Oct;107(10):1499-1505. doi: 10.1111/cas.13021. Epub 2016 Oct 3.
|
| 130 |
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.J Biol Chem. 2015 May 29;290(22):13641-53. doi: 10.1074/jbc.M114.626861. Epub 2015 Mar 30.
|
| 131 |
Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.Tumour Biol. 2014 Dec;35(12):11871-7. doi: 10.1007/s13277-014-2429-4. Epub 2014 Aug 21.
|
| 132 |
Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer. 2008 Jan 1;112(1):43-9. doi: 10.1002/cncr.23135.
|
| 133 |
CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.Med Oncol. 2011 Mar;28(1):182-7. doi: 10.1007/s12032-010-9455-x. Epub 2010 Mar 2.
|
| 134 |
STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.Ann Surg Oncol. 2011 Jan;18(1):261-72. doi: 10.1245/s10434-010-1271-1. Epub 2010 Aug 24.
|
| 135 |
Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/-catenin signal pathway in colorectal cancer and predicts poor prognosis.Pathol Res Pract. 2019 Jan;215(1):57-67. doi: 10.1016/j.prp.2018.10.018. Epub 2018 Oct 24.
|
| 136 |
A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.Br J Cancer. 2000 May;82(9):1557-60. doi: 10.1054/bjoc.1999.1178.
|
| 137 |
Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer.Cancer Genet. 2015 Dec;208(12):595-601. doi: 10.1016/j.cancergen.2015.09.008. Epub 2015 Oct 9.
|
| 138 |
Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.Toxicol Appl Pharmacol. 2018 Aug 1;352:46-58. doi: 10.1016/j.taap.2018.05.026. Epub 2018 May 22.
|
| 139 |
Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.Cancer. 2014 Mar 15;120(6):808-17. doi: 10.1002/cncr.28491. Epub 2013 Nov 18.
|
| 140 |
(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity.Cancers (Basel). 2019 Dec 6;11(12):1964. doi: 10.3390/cancers11121964.
|
| 141 |
53BP1 regulates cell cycle arrest in esophageal cancer model.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):604-612. doi: 10.26355/eurrev_201901_16874.
|
| 142 |
An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-B Signaling.Cancer Res. 2018 Nov 15;78(22):6399-6412. doi: 10.1158/0008-5472.CAN-18-2063. Epub 2018 Sep 25.
|
| 143 |
TRPM8 facilitates proliferation and immune evasion of esophageal cancer cells.Biosci Rep. 2019 Oct 30;39(10):BSR20191878. doi: 10.1042/BSR20191878.
|
| 144 |
Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer.Oncol Lett. 2017 Jun;13(6):4245-4251. doi: 10.3892/ol.2017.6023. Epub 2017 Apr 11.
|
| 145 |
Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.J Cancer Res Clin Oncol. 2019 Feb;145(2):281-291. doi: 10.1007/s00432-019-02840-3. Epub 2019 Jan 17.
|
| 146 |
Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.Exp Cell Res. 2019 Feb 15;375(2):41-50. doi: 10.1016/j.yexcr.2019.01.002. Epub 2019 Jan 3.
|
| 147 |
UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells.Oncotarget. 2017 Apr 4;8(14):23479-23491. doi: 10.18632/oncotarget.15182.
|
| 148 |
PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.Cancer Res. 2005 Jun 1;65(11):4963-8. doi: 10.1158/0008-5472.CAN-04-3923.
|
| 149 |
The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.J Mol Med (Berl). 2009 Mar;87(3):307-20. doi: 10.1007/s00109-008-0430-3. Epub 2008 Dec 16.
|
| 150 |
Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients.Med Oncol. 2013;30(3):630. doi: 10.1007/s12032-013-0630-8. Epub 2013 Jun 20.
|
| 151 |
High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.Oncology. 2009;76(5):342-9. doi: 10.1159/000209964. Epub 2009 Mar 23.
|
| 152 |
Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis.Mol Carcinog. 2019 Jan;58(1):42-54. doi: 10.1002/mc.22905. Epub 2018 Sep 21.
|
| 153 |
Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers.Hum Pathol. 2018 May;75:116-124. doi: 10.1016/j.humpath.2018.02.008. Epub 2018 Feb 13.
|
| 154 |
T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.Immunol Res. 2011 Aug;50(2-3):269-75. doi: 10.1007/s12026-011-8227-9.
|
| 155 |
X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF- signaling pathway in esophageal cancer cells.Cell Biosci. 2019 Sep 18;9:76. doi: 10.1186/s13578-019-0338-3. eCollection 2019.
|
| 156 |
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.Cancer Res. 2019 Nov 15;79(22):5734-5745. doi: 10.1158/0008-5472.CAN-18-3376. Epub 2019 Aug 7.
|
| 157 |
A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma. Oncogene. 2008 May 8;27(21):2951-60.
|
| 158 |
Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer.Surgery. 2005 Aug;138(2):261-8. doi: 10.1016/j.surg.2005.04.011.
|
| 159 |
Up-regulation of Frizzled-7 (FZD7) in human gastric cancer.Int J Oncol. 2001 Jul;19(1):111-5.
|
| 160 |
Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.Cancer Res. 2001 Aug 1;61(15):5714-7.
|
| 161 |
Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.Oncotarget. 2018 Jan 13;9(13):11009-11019. doi: 10.18632/oncotarget.24232. eCollection 2018 Feb 16.
|
| 162 |
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.Cancer Sci. 2007 Nov;98(11):1803-8. doi: 10.1111/j.1349-7006.2007.00603.x.
|
| 163 |
Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.Oncol Rep. 2006 Jun;15(6):1529-32.
|
| 164 |
Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray.Int J Cancer. 2007 Jan 15;120(2):230-42. doi: 10.1002/ijc.22246.
|
| 165 |
HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.Ann Thorac Surg. 2018 Feb;105(2):363-370. doi: 10.1016/j.athoracsur.2017.09.003. Epub 2017 Dec 7.
|
| 166 |
Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.Clin Cancer Res. 1999 Dec;5(12):4073-8.
|
| 167 |
Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer.Gene. 2001 Jan 24;263(1-2):205-9. doi: 10.1016/s0378-1119(00)00570-9.
|
| 168 |
LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis.Oncogene. 2015 Sep 3;34(36):4723-34. doi: 10.1038/onc.2014.400. Epub 2014 Dec 8.
|
| 169 |
Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues.Cancer Res. 1998 Nov 1;58(21):4802-4.
|
| 170 |
Effects of silencing the ATP-binding cassette protein E1 gene by electroporation on the proliferation and migration of EC109 human esophageal cancer cells.Mol Med Rep. 2015 Jul;12(1):837-42. doi: 10.3892/mmr.2015.3512. Epub 2015 Mar 19.
|
| 171 |
Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.Cell Physiol Biochem. 2018;47(5):1785-1799. doi: 10.1159/000491060. Epub 2018 Jun 28.
|
| 172 |
High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.Int J Oncol. 2012 Jun;40(6):1789-96. doi: 10.3892/ijo.2012.1385. Epub 2012 Feb 22.
|
| 173 |
Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.Biomol Ther (Seoul). 2018 Jul 1;26(4):399-408. doi: 10.4062/biomolther.2017.113.
|
| 174 |
Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population.Cancer Genet Cytogenet. 2005 May;159(1):48-52. doi: 10.1016/j.cancergencyto.2004.09.017.
|
| 175 |
SULT1A1 polymorphism and esophageal cancer in males.Int J Cancer. 2003 Jan 1;103(1):101-4. doi: 10.1002/ijc.10805.
|
| 176 |
Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Oncol Rep. 2006 Jun;15(6):1551-5.
|
| 177 |
Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis.World J Surg Oncol. 2016 Jul 22;14(1):191. doi: 10.1186/s12957-016-0937-y.
|
| 178 |
A summary of meat intakes and health burdens.Eur J Clin Nutr. 2018 Jan;72(1):18-29. doi: 10.1038/ejcn.2017.117. Epub 2017 Aug 9.
|
| 179 |
The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.Int Immunopharmacol. 2017 May;46:75-79. doi: 10.1016/j.intimp.2017.02.027. Epub 2017 Mar 6.
|
| 180 |
Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer.Cancer Cell Int. 2018 Oct 22;18:168. doi: 10.1186/s12935-018-0657-1. eCollection 2018.
|
| 181 |
Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2006 Jun 28;12(24):3929-32. doi: 10.3748/wjg.v12.i24.3929.
|
| 182 |
Expression of basic fibroblast growth factor, CD31, and -smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation.Tumour Biol. 2014 Jul;35(7):7275-82. doi: 10.1007/s13277-014-1987-9. Epub 2014 Apr 29.
|
| 183 |
Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9.Oncogene. 2007 Jan 4;26(1):148-57. doi: 10.1038/sj.onc.1209767. Epub 2006 Jun 26.
|
| 184 |
Cinobufagin Promotes Cell Cycle Arrest and Apoptosis to Block Human Esophageal Squamous Cell Carcinoma Cells Growth via the p73 Signalling Pathway.Biol Pharm Bull. 2019;42(9):1500-1509. doi: 10.1248/bpb.b19-00174.
|
| 185 |
Esophagin cDNA cloning and characterization: a tissue-specific member of the small proline-rich protein family that is not expressed in esophageal tumors.Cell Growth Differ. 1996 Jul;7(7):855-60.
|
| 186 |
Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.Gut. 2010 Nov;59(11):1457-64. doi: 10.1136/gut.2009.205724. Epub 2010 Sep 9.
|
| 187 |
Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.Med Sci Monit. 2016 Aug 10;22:2816-24. doi: 10.12659/msm.896877.
|
| 188 |
CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics. 2010 Aug;11(8):1105-13. doi: 10.2217/pgs.10.76.
|
| 189 |
RNASEN regulates cell proliferation and affects survival in esophageal cancer patients.Clin Cancer Res. 2006 Dec 15;12(24):7322-8. doi: 10.1158/1078-0432.CCR-06-0515. Epub 2006 Nov 22.
|
| 190 |
Preparation and characterization of a novel monoclonal antibody specific to human EMILIN-5 protein.Hybridoma (Larchmt). 2007 Dec;26(6):417-21. doi: 10.1089/hyb.2007.0528.
|
| 191 |
A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies.Carcinogenesis. 2008 Feb;29(2):418-26. doi: 10.1093/carcin/bgm225. Epub 2008 Jan 3.
|
| 192 |
Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.Genomics. 1999 Jul 15;59(2):234-42. doi: 10.1006/geno.1999.5857.
|
| 193 |
Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.Gene Ther. 2016 Jan;23(1):50-6. doi: 10.1038/gt.2015.84. Epub 2015 Aug 4.
|
| 194 |
Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.Int J Oncol. 2008 Feb;32(2):413-23.
|
| 195 |
Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11157-63. eCollection 2015.
|
| 196 |
Latent transforming growth factor -binding protein 4 is downregulated in esophageal cancer via promoter methylation.PLoS One. 2013 May 31;8(5):e65614. doi: 10.1371/journal.pone.0065614. Print 2013.
|
| 197 |
Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer.World J Gastroenterol. 2006 Sep 7;12(33):5281-6. doi: 10.3748/wjg.v12.i33.5281.
|
| 198 |
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54.Nat Genet. 2010 Sep;42(9):759-63. doi: 10.1038/ng.648. Epub 2010 Aug 22.
|
| 199 |
Ecrg4 deficiency extends the replicative capacity of neural stem cells in a Foxg1-dependent manner.Development. 2019 Feb 18;146(4):dev168120. doi: 10.1242/dev.168120.
|
| 200 |
Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.Dis Esophagus. 2018 Feb 1;31(2). doi: 10.1093/dote/dox117.
|
| 201 |
Promotion of cellular senescence by THG-1/TSC22D4 knockout through activation of JUNB.Biochem Biophys Res Commun. 2020 Feb 19;522(4):897-902. doi: 10.1016/j.bbrc.2019.11.145. Epub 2019 Dec 3.
|
| 202 |
Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.
|
| 203 |
Natural antisense transcript TPM1-AS regulates the alternative splicing of tropomyosin I through an interaction with RNA-binding motif protein 4.Int J Biochem Cell Biol. 2017 Sep;90:59-67. doi: 10.1016/j.biocel.2017.07.017. Epub 2017 Jul 25.
|
| 204 |
TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression.Clin Exp Metastasis. 2008;25(5):537-48. doi: 10.1007/s10585-008-9168-0. Epub 2008 Mar 26.
|
| 205 |
Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.Cancer Invest. 1997;15(5):411-5. doi: 10.3109/07357909709047579.
|
| 206 |
Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer.Clin Cancer Res. 1999 Dec;5(12):4233-41.
|
| 207 |
The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.Dis Esophagus. 1999;12(3):173-6. doi: 10.1046/j.1442-2050.1999.00042.x.
|
| 208 |
The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012.J Surg Oncol. 2017 Mar;115(3):296-300. doi: 10.1002/jso.24493. Epub 2016 Nov 4.
|
| 209 |
An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.Cancer Lett. 2018 May 28;422:118-128. doi: 10.1016/j.canlet.2018.02.031. Epub 2018 Feb 21.
|
| 210 |
Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma.Cancer Sci. 2010 Apr;101(4):1038-44. doi: 10.1111/j.1349-7006.2009.01477.x. Epub 2009 Dec 16.
|
| 211 |
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):111-7. doi: 10.1158/1055-9965.EPI-07-0407.
|
| 212 |
Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma.Dig Liver Dis. 2019 Oct;51(10):1475-1482. doi: 10.1016/j.dld.2019.04.018. Epub 2019 May 31.
|
| 213 |
Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression.Genet Mol Res. 2016 Jun 24;15(2). doi: 10.4238/gmr.15028318.
|
| 214 |
Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.J Toxicol Environ Health A. 2007 Jun;70(11):885-94. doi: 10.1080/15287390701285915.
|
| 215 |
Vacuolar H(+)-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling.Cells. 2019 Sep 24;8(10):1137. doi: 10.3390/cells8101137.
|
| 216 |
Gene expression profiling and pathway network analysis of anti-tumor activity by Jaridon 6 in esophageal cancer.Eur J Pharmacol. 2017 Nov 15;815:478-486. doi: 10.1016/j.ejphar.2017.08.004. Epub 2017 Aug 9.
|
| 217 |
Expression of BAG-1 is closely related to cell differentiation and TNM stage in esophageal cancer and its downregulation inhibits the proliferation and invasion of human esophageal carcinoma cells.Oncol Rep. 2014 Oct;32(4):1441-6. doi: 10.3892/or.2014.3356. Epub 2014 Jul 23.
|
| 218 |
Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.Acta Oncol. 2018 Sep;57(9):1192-1200. doi: 10.1080/0284186X.2018.1450521. Epub 2018 Mar 12.
|
| 219 |
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics J. 2009 Jun;9(3):202-7. doi: 10.1038/tpj.2009.5. Epub 2009 Mar 10.
|
| 220 |
Expression of VRK1 and the downstream gene BANF1 in esophageal cancer.Biomed Pharmacother. 2017 May;89:1086-1091. doi: 10.1016/j.biopha.2017.02.095. Epub 2017 Mar 11.
|
| 221 |
miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.Oncol Rep. 2018 Jan;39(1):71-80. doi: 10.3892/or.2017.6064. Epub 2017 Nov 1.
|
| 222 |
Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.Oncotarget. 2016 Apr 12;7(15):19960-74. doi: 10.18632/oncotarget.6963.
|
| 223 |
A role for the clock period circadian regulator 2 gene in regulating the clock gene network in human oral squamous cell carcinoma cells.Oncol Lett. 2018 Apr;15(4):4185-4192. doi: 10.3892/ol.2018.7825. Epub 2018 Jan 19.
|
| 224 |
MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2.Biomed Pharmacother. 2018 Sep;105:582-589. doi: 10.1016/j.biopha.2018.05.152. Epub 2018 Jun 8.
|
| 225 |
Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying 1-integrin glycosylation.J Cancer. 2018 Jun 23;9(15):2666-2677. doi: 10.7150/jca.25252. eCollection 2018.
|
| 226 |
The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Oncol Rep. 2007 Sep;18(3):601-9.
|
| 227 |
Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer.Int J Cancer. 2007 Apr 15;120(8):1739-47. doi: 10.1002/ijc.22463.
|
| 228 |
Circulating Inflammation Markers and Risk of Gastric and Esophageal Cancers: A Case-Cohort Study Within the Japan Public Health Center-Based Prospective Study.Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):829-832. doi: 10.1158/1055-9965.EPI-18-1157. Epub 2019 Mar 15.
|
| 229 |
WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice.PLoS One. 2014 Apr 11;9(4):e94751. doi: 10.1371/journal.pone.0094751. eCollection 2014.
|
| 230 |
WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.J Exp Clin Cancer Res. 2019 Feb 26;38(1):102. doi: 10.1186/s13046-019-1108-0.
|
| 231 |
Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.Tumour Biol. 2014 Apr;35(4):3355-62. doi: 10.1007/s13277-013-1442-3. Epub 2013 Dec 3.
|
| 232 |
Role of interleukin 1 beta in esophageal squamous cell carcinoma.J Mol Med (Berl). 2012 Jan;90(1):89-100. doi: 10.1007/s00109-011-0809-4. Epub 2011 Sep 13.
|
| 233 |
Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S640-7. doi: 10.1245/s10434-014-3740-4. Epub 2014 May 22.
|
| 234 |
PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.PLoS One. 2015 Oct 21;10(10):e0140451. doi: 10.1371/journal.pone.0140451. eCollection 2015.
|
| 235 |
CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer.Cancer Manag Res. 2019 Apr 15;11:3253-3264. doi: 10.2147/CMAR.S193793. eCollection 2019.
|
| 236 |
Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.Oncogene. 2016 Apr 21;35(16):2087-97. doi: 10.1038/onc.2015.271. Epub 2015 Aug 3.
|
| 237 |
ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.Life Sci. 2019 Sep 1;232:116679. doi: 10.1016/j.lfs.2019.116679. Epub 2019 Jul 21.
|
| 238 |
Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).PLoS One. 2014 Mar 12;9(3):e90836. doi: 10.1371/journal.pone.0090836. eCollection 2014.
|
| 239 |
Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.J Oral Pathol Med. 2017 Sep;46(8):583-590. doi: 10.1111/jop.12538. Epub 2017 Jun 5.
|
| 240 |
The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.Oncotarget. 2016 Feb 2;7(5):5495-506. doi: 10.18632/oncotarget.6747.
|
| 241 |
Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression.Esophagus. 2020 Apr;17(2):159-167. doi: 10.1007/s10388-019-00695-8. Epub 2019 Oct 8.
|
| 242 |
CRCT1 regulated by microRNA-520g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.Tumour Biol. 2016 Jun;37(6):8271-9. doi: 10.1007/s13277-015-4730-2. Epub 2015 Dec 30.
|
| 243 |
Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.World J Gastroenterol. 2013 Jul 14;19(26):4127-36. doi: 10.3748/wjg.v19.i26.4127.
|
| 244 |
Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.
|
| 245 |
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.Genes Chromosomes Cancer. 2006 Apr;45(4):392-400. doi: 10.1002/gcc.20298.
|
| 246 |
C-terminal binding protein? mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.Int J Oncol. 2018 Jul;53(1):167-176. doi: 10.3892/ijo.2018.4367. Epub 2018 Apr 12.
|
| 247 |
Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors.Int J Oncol. 1999 Jan;14(1):33-40.
|
| 248 |
Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through Targeting CTNNA2.DNA Cell Biol. 2019 Feb;38(2):151-161. doi: 10.1089/dna.2018.4377. Epub 2018 Dec 8.
|
| 249 |
Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S767-75. doi: 10.1245/s10434-014-4009-7. Epub 2014 Sep 12.
|
| 250 |
Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Int J Clin Oncol. 2020 Mar;25(3):446-455. doi: 10.1007/s10147-019-01547-2. Epub 2019 Sep 18.
|
| 251 |
Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF- signaling.PLoS One. 2014 Apr 17;9(4):e95509. doi: 10.1371/journal.pone.0095509. eCollection 2014.
|
| 252 |
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.J Biomed Sci. 2017 Jan 11;24(1):6. doi: 10.1186/s12929-016-0308-6.
|
| 253 |
Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.Ann Surg Oncol. 2009 May;16(5):1378-83. doi: 10.1245/s10434-009-0356-1. Epub 2009 Feb 18.
|
| 254 |
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.Cancer Res. 1992 Dec 1;52(23):6525-30.
|
| 255 |
Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.Gastroenterology. 2015 Dec;149(7):1825-1836.e5. doi: 10.1053/j.gastro.2015.08.025. Epub 2015 Aug 22.
|
| 256 |
Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.Hum Pathol. 2010 Oct;41(10):1456-65. doi: 10.1016/j.humpath.2010.04.003.
|
| 257 |
EMP3 as a candidate tumor suppressor gene for solid tumors.Expert Opin Ther Targets. 2009 Jul;13(7):811-22. doi: 10.1517/14728220902988549.
|
| 258 |
Transcriptional regulation of miR-146b by C/EBP LAP2 in esophageal cancer cells.Biochem Biophys Res Commun. 2014 Mar 28;446(1):267-71. doi: 10.1016/j.bbrc.2014.02.096. Epub 2014 Feb 28.
|
| 259 |
Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype.Oncol Lett. 2018 Aug;16(2):2539-2548. doi: 10.3892/ol.2018.8894. Epub 2018 Jun 4.
|
| 260 |
Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.Front Oncol. 2019 Feb 21;9:85. doi: 10.3389/fonc.2019.00085. eCollection 2019.
|
| 261 |
Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.Oncol Rep. 2004 Oct;12(4):827-31.
|
| 262 |
Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.J Exp Clin Cancer Res. 2009 Nov 25;28(1):145. doi: 10.1186/1756-9966-28-145.
|
| 263 |
Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer.Acta Oncol. 2017 Nov;56(11):1495-1500. doi: 10.1080/0284186X.2017.1349928. Epub 2017 Aug 25.
|
| 264 |
Nonsynonymous polymorphisms in FAT4 gene are associated with the risk of esophageal cancer in an Eastern Chinese population.Int J Cancer. 2013 Jul 15;133(2):357-61. doi: 10.1002/ijc.28033. Epub 2013 Feb 12.
|
| 265 |
Migfilin regulates esophageal cancer cell motility through promoting GSK-3-mediated degradation of -catenin.Mol Cancer Res. 2012 Mar;10(3):273-81. doi: 10.1158/1541-7786.MCR-11-0419. Epub 2012 Jan 13.
|
| 266 |
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance.Theranostics. 2019 Feb 28;9(6):1599-1613. doi: 10.7150/thno.30372. eCollection 2019.
|
| 267 |
Aberrant methylation and decreased expression of the TGF-/Smad target gene FBXO32 in esophageal squamous cell carcinoma.Cancer. 2014 Aug 15;120(16):2412-23. doi: 10.1002/cncr.28764. Epub 2014 May 2.
|
| 268 |
The Effect of FERMT1 Regulated by miR-24 on the Growth and Radiation Resistance of Esophageal Cancer.J Biomed Nanotechnol. 2019 Mar 1;15(3):621-631. doi: 10.1166/jbn.2019.2711.
|
| 269 |
Differential expression of Kindlin-1 and Kindlin-2 correlates with esophageal cancer progression and epidemiology.Sci China Life Sci. 2017 Nov;60(11):1214-1222. doi: 10.1007/s11427-016-9044-5. Epub 2017 Jun 29.
|
| 270 |
Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer.Radiat Oncol. 2019 Feb 4;14(1):27. doi: 10.1186/s13014-019-1232-1.
|
| 271 |
Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.OMICS. 2017 Oct;21(10):616-631. doi: 10.1089/omi.2017.0116.
|
| 272 |
NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.Cancer Lett. 2016 Sep 28;380(1):47-58. doi: 10.1016/j.canlet.2016.06.009. Epub 2016 Jun 15.
|
| 273 |
Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.Oncol Lett. 2019 May;17(5):4351-4360. doi: 10.3892/ol.2019.10078. Epub 2019 Feb 26.
|
| 274 |
FOXK1 plays an oncogenic role in the development of esophageal cancer.Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):88-94. doi: 10.1016/j.bbrc.2017.10.080. Epub 2017 Oct 16.
|
| 275 |
FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.Int J Cancer. 2008 Aug 1;123(3):561-8. doi: 10.1002/ijc.23600.
|
| 276 |
The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3 activity in cell growth of esophageal carcinoma.Tumour Biol. 2014 Feb;35(2):995-1002. doi: 10.1007/s13277-013-1133-0.
|
| 277 |
Effect of GDF11 on proliferation and apoptosis of esophageal cancer cells.Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):80-84.
|
| 278 |
MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma.Mol Genet Genomics. 2014 Dec;289(6):1123-30. doi: 10.1007/s00438-014-0873-x. Epub 2014 Jun 12.
|
| 279 |
RMP promotes the proliferation and radioresistance of esophageal carcinoma.J Cancer. 2019 Jun 9;10(16):3698-3705. doi: 10.7150/jca.32680. eCollection 2019.
|
| 280 |
High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.PLoS One. 2012;7(10):e45622. doi: 10.1371/journal.pone.0045622. Epub 2012 Oct 2.
|
| 281 |
High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.
|
| 282 |
ERBB2 amplifications in esophageal adenocarcinoma.Ann Thorac Surg. 2004 Nov;78(5):1790-800. doi: 10.1016/j.athoracsur.2004.05.037.
|
| 283 |
Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.Nutr Cancer. 2010;62(6):734-42. doi: 10.1080/01635581003605904.
|
| 284 |
miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer.Biochem Biophys Res Commun. 2017 Apr 1;485(2):506-512. doi: 10.1016/j.bbrc.2017.02.016. Epub 2017 Feb 9.
|
| 285 |
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.Cancer Sci. 2019 Oct;110(10):3049-3060. doi: 10.1111/cas.14165. Epub 2019 Sep 19.
|
| 286 |
Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus.Tumour Biol. 2014 May;35(5):4907-12. doi: 10.1007/s13277-014-1644-3. Epub 2014 Jan 29.
|
| 287 |
Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers.Cancer Res. 2008 Feb 15;68(4):1136-43. doi: 10.1158/0008-5472.CAN-07-5021.
|
| 288 |
Associations between polymorphisms in IL-12A, IL-12B, IL-12R1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer.J Cancer Res Clin Oncol. 2012 Nov;138(11):1891-900. doi: 10.1007/s00432-012-1269-0. Epub 2012 Jun 28.
|
| 289 |
Overexpression of Ets-like protein 1 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2006 Dec 28;12(48):7859-63. doi: 10.3748/wjg.v12.i48.7859.
|
| 290 |
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity invitro.Oncol Rep. 2015 Nov;34(5):2325-32. doi: 10.3892/or.2015.4211. Epub 2015 Aug 20.
|
| 291 |
Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.FASEB J. 2019 Sep;33(9):10490-10504. doi: 10.1096/fj.201802543RR. Epub 2019 Jul 15.
|
| 292 |
Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.Oncol Res. 2016;24(4):247-53. doi: 10.3727/096504016X14652175055765.
|
| 293 |
LMX1B involved in the radioresistance, proliferation and migration of esophageal cancer cells.Biomed Pharmacother. 2019 Oct;118:109358. doi: 10.1016/j.biopha.2019.109358. Epub 2019 Aug 29.
|
| 294 |
Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.Tumour Biol. 2016 Jul;37(7):8741-52. doi: 10.1007/s13277-015-4747-6. Epub 2016 Jan 7.
|
| 295 |
Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.Dis Esophagus. 2015 Feb-Mar;28(2):188-95. doi: 10.1111/dote.12156. Epub 2013 Oct 21.
|
| 296 |
Loss of MAL expression in precancerous lesions of the esophagus.Ann Surg Oncol. 2007 May;14(5):1670-7. doi: 10.1245/s10434-006-9064-2. Epub 2006 Dec 6.
|
| 297 |
Role of MAML1 in targeted therapy against the esophageal cancer stem cells.J Transl Med. 2019 Apr 16;17(1):126. doi: 10.1186/s12967-019-1876-5.
|
| 298 |
Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.Cancer Lett. 2019 Feb 1;442:126-136. doi: 10.1016/j.canlet.2018.10.016. Epub 2018 Nov 2.
|
| 299 |
Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.Medicine (Baltimore). 2019 Mar;98(13):e14855. doi: 10.1097/MD.0000000000014855.
|
| 300 |
Increased expression of MARCH8, an E3 ubiquitin ligase, is associated with growth of esophageal tumor.Cancer Cell Int. 2017 Dec 4;17:116. doi: 10.1186/s12935-017-0490-y. eCollection 2017.
|
| 301 |
Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells.Mol Cell Biochem. 2010 Sep;342(1-2):1-6. doi: 10.1007/s11010-010-0460-3. Epub 2010 Apr 3.
|
| 302 |
Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics.IUBMB Life. 2019 Feb;71(2):254-260. doi: 10.1002/iub.1971. Epub 2018 Nov 30.
|
| 303 |
The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.Cells. 2019 Oct 30;8(11):1357. doi: 10.3390/cells8111357.
|
| 304 |
Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.Cancer Lett. 2018 Apr 1;418:97-108. doi: 10.1016/j.canlet.2018.01.022. Epub 2018 Jan 10.
|
| 305 |
LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis.Eur Rev Med Pharmacol Sci. 2018 May;22(9):2653-2661. doi: 10.26355/eurrev_201805_14961.
|
| 306 |
Effects of metallothionein-3 and metallothionein-1E gene transfection on proliferation, cell cycle, and apoptosis of esophageal cancer cells.Genet Mol Res. 2013 Oct 17;12(4):4595-603. doi: 10.4238/2013.October.17.2.
|
| 307 |
The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.Scand J Gastroenterol. 2018 May;53(5):533-540. doi: 10.1080/00365521.2017.1407440. Epub 2017 Nov 24.
|
| 308 |
Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.J Clin Lab Anal. 2018 Feb;32(2):e22248. doi: 10.1002/jcla.22248. Epub 2017 May 2.
|
| 309 |
Association between genetic variants and esophageal cancer risk.Oncotarget. 2017 Jul 18;8(29):47167-47174. doi: 10.18632/oncotarget.17006.
|
| 310 |
Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies.World J Gastroenterol. 2016 Feb 7;22(5):1911-8. doi: 10.3748/wjg.v22.i5.1911.
|
| 311 |
High incidence of coding gene mutations in mitochondrial DNA in esophageal cancer.Mol Med Rep. 2017 Dec;16(6):8537-8541. doi: 10.3892/mmr.2017.7663. Epub 2017 Sep 29.
|
| 312 |
A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.Cancer. 2013 Dec 1;119(23):4205-11. doi: 10.1002/cncr.28338. Epub 2013 Sep 10.
|
| 313 |
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.J Thorac Oncol. 2016 Nov;11(11):1912-1926. doi: 10.1016/j.jtho.2016.06.015. Epub 2016 Jun 30.
|
| 314 |
Nkx2-8 downregulation promotes angiogenesis and activates NF-B in esophageal cancer.Cancer Res. 2013 Jun 15;73(12):3638-48. doi: 10.1158/0008-5472.CAN-12-4028. Epub 2013 Apr 19.
|
| 315 |
Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.Cancer Sci. 2017 May;108(5):910-917. doi: 10.1111/cas.13204. Epub 2017 Apr 24.
|
| 316 |
MicroRNA-548-3p and MicroRNA-576-5p enhance the migration and invasion of esophageal squamous cell carcinoma cells via NRIP1 down-regulation.Neoplasma. 2018 Nov 15;65(6):881-887. doi: 10.4149/neo_2018_171206N803. Epub 2018 Jun 17.
|
| 317 |
Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.Cancer Sci. 2012 Mar;103(3):577-86. doi: 10.1111/j.1349-7006.2011.02167.x. Epub 2012 Jan 9.
|
| 318 |
Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer.Front Oncol. 2019 Mar 15;9:147. doi: 10.3389/fonc.2019.00147. eCollection 2019.
|
| 319 |
OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.Oncogene. 2018 Jun;37(25):3356-3368. doi: 10.1038/s41388-018-0224-1. Epub 2018 Mar 21.
|
| 320 |
Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.Epigenetics. 2008 Nov;3(6):336-41. doi: 10.4161/epi.3.6.7158. Epub 2008 Nov 8.
|
| 321 |
Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2018 Apr;15(4):5703-5711. doi: 10.3892/ol.2018.8004. Epub 2018 Feb 8.
|
| 322 |
FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.Am J Cancer Res. 2017 Aug 1;7(8):1642-1653. eCollection 2017.
|
| 323 |
Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.Lab Invest. 2013 Dec;93(12):1276-87. doi: 10.1038/labinvest.2013.124. Epub 2013 Oct 21.
|
| 324 |
Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1513-1519. doi: 10.26355/eurrev_201902_17109.
|
| 325 |
Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6.J BUON. 2019 Mar-Apr;24(2):805-812.
|
| 326 |
PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo.Onco Targets Ther. 2019 Nov 18;12:9899-9913. doi: 10.2147/OTT.S226851. eCollection 2019.
|
| 327 |
Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells.Cancer Gene Ther. 2015 Apr;22(3):138-44. doi: 10.1038/cgt.2014.77. Epub 2015 Jan 16.
|
| 328 |
The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis.Tumour Biol. 2016 Apr;37(4):5317-25. doi: 10.1007/s13277-015-4250-0. Epub 2015 Nov 11.
|
| 329 |
Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclinD1.Oncol Rep. 2016 Jun;35(6):3532-40. doi: 10.3892/or.2016.4731. Epub 2016 Apr 4.
|
| 330 |
PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKC/NF-B Pathway.Yonsei Med J. 2018 Dec;59(10):1159-1165. doi: 10.3349/ymj.2018.59.10.1159.
|
| 331 |
The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
|
| 332 |
Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.Mol Carcinog. 2018 Jul;57(7):886-895. doi: 10.1002/mc.22809. Epub 2018 Apr 6.
|
| 333 |
Long-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cells. Dig Dis Sci. 2013 Mar;58(3):694-8.
|
| 334 |
Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells.BMC Cell Biol. 2011 Sep 27;12:41. doi: 10.1186/1471-2121-12-41.
|
| 335 |
Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.Cell Death Dis. 2019 Dec 5;10(12):930. doi: 10.1038/s41419-019-2171-3.
|
| 336 |
PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.Anticancer Res. 2018 Nov;38(11):6139-6145. doi: 10.21873/anticanres.12966.
|
| 337 |
Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation.Acta Pharmacol Sin. 2011 Apr;32(4):528-36. doi: 10.1038/aps.2010.235.
|
| 338 |
POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim.Neoplasia. 2018 May;20(5):411-424. doi: 10.1016/j.neo.2018.02.005. Epub 2018 Mar 21.
|
| 339 |
PSMD4 regulates the malignancy of esophageal cancer cells by suppressing endoplasmic reticulum stress.Kaohsiung J Med Sci. 2019 Oct;35(10):591-597. doi: 10.1002/kjm2.12093. Epub 2019 Jun 4.
|
| 340 |
Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.Carcinogenesis. 2009 May;30(5):785-92. doi: 10.1093/carcin/bgp058. Epub 2009 Mar 6.
|
| 341 |
Knockdown of Rad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells.Tumour Biol. 2016 Jan;37(1):963-70. doi: 10.1007/s13277-015-3879-z. Epub 2015 Aug 12.
|
| 342 |
Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.Discov Med. 2014 Apr;17(94):169-78.
|
| 343 |
Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2016 Jan;33(1):73-85. doi: 10.1007/s10585-015-9759-5.
|
| 344 |
Proliferation Potential-Related Protein Promotes the Esophageal Cancer Cell Proliferation, Migration and Suppresses Apoptosis by Mediating the Expression of p53 and Interleukin-17.Pathobiology. 2018;85(5-6):322-331. doi: 10.1159/000492393. Epub 2018 Sep 17.
|
| 345 |
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.BMC Cancer. 2018 Nov 12;18(1):1106. doi: 10.1186/s12885-018-5032-z.
|
| 346 |
Retinoblastoma-binding protein 2 induces epithelial-mesenchymal transition in esophageal squamous cancer cells.Biotechnol Lett. 2015 Dec;37(12):2365-70. doi: 10.1007/s10529-015-1925-y. Epub 2015 Aug 12.
|
| 347 |
Targeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cells.Oncotarget. 2017 Apr 25;8(17):29125-29137. doi: 10.18632/oncotarget.16250.
|
| 348 |
SLC52A3 expression is activated by NF-B p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.Cell Mol Life Sci. 2018 Jul;75(14):2643-2661. doi: 10.1007/s00018-018-2757-4. Epub 2018 Feb 10.
|
| 349 |
RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis.Clin Exp Metastasis. 2011 Aug;28(6):541-9. doi: 10.1007/s10585-011-9390-z. Epub 2011 May 1.
|
| 350 |
Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung.Biochem Cell Biol. 2019 Oct;97(5):589-599. doi: 10.1139/bcb-2018-0252. Epub 2019 Jan 23.
|
| 351 |
Enhanced radiosensitivity and G2/M arrest were observed in radioresistant esophageal cancer cells by knocking down RPA expression.Cell Biochem Biophys. 2014 Nov;70(2):887-91. doi: 10.1007/s12013-014-9995-3.
|
| 352 |
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.Cell Physiol Biochem. 2017;42(6):2267-2280. doi: 10.1159/000480000. Epub 2017 Aug 17.
|
| 353 |
Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo.Biosci Rep. 2019 May 7;39(5):BSR20182448. doi: 10.1042/BSR20182448. Print 2019 May 31.
|
| 354 |
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.Clin Cancer Res. 2006 Nov 15;12(22):6637-42. doi: 10.1158/1078-0432.CCR-06-1781.
|
| 355 |
Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.Anticancer Res. 2013 Nov;33(11):5199-203.
|
| 356 |
siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.World J Gastroenterol. 2012 Aug 21;18(31):4127-35. doi: 10.3748/wjg.v18.i31.4127.
|
| 357 |
A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.Int J Oncol. 2007 Feb;30(2):421-8.
|
| 358 |
S100A14: novel modulator of terminal differentiation in esophageal cancer.Mol Cancer Res. 2013 Dec;11(12):1542-53. doi: 10.1158/1541-7786.MCR-13-0317. Epub 2013 Oct 9.
|
| 359 |
Genetic epidemiological analysis of esophageal cancer in high-incidence areas of China.Asian Pac J Cancer Prev. 2014;15(22):9859-63. doi: 10.7314/apjcp.2014.15.22.9859.
|
| 360 |
mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.J Cancer. 2017 Feb 25;8(4):646-656. doi: 10.7150/jca.15652. eCollection 2017.
|
| 361 |
A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells.Anticancer Agents Med Chem. 2018;18(3):394-400. doi: 10.2174/1871520617666170522123742.
|
| 362 |
Analysis of Sciellin (SCEL) as a candidate gene in esophageal squamous cell carcinoma.Anticancer Res. 2004 May-Jun;24(3a):1417-9.
|
| 363 |
SEL1L and squamous cell carcinoma of the esophagus.Clin Cancer Res. 2004 Sep 1;10(17):5857-61. doi: 10.1158/1078-0432.CCR-04-0075.
|
| 364 |
High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.Pathol Int. 2018 Dec;68(12):685-693. doi: 10.1111/pin.12736. Epub 2018 Dec 5.
|
| 365 |
Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.Anticancer Drugs. 2019 Jul;30(6):596-603. doi: 10.1097/CAD.0000000000000751.
|
| 366 |
p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.Ann Surg Oncol. 2010 May;17(5):1453-8. doi: 10.1245/s10434-009-0882-x. Epub 2010 Jan 29.
|
| 367 |
MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5.Scand J Gastroenterol. 2018 Jun-Jul;53(7):769-776. doi: 10.1080/00365521.2018.1476913. Epub 2018 May 31.
|
| 368 |
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.Sci Rep. 2019 Aug 12;9(1):11661. doi: 10.1038/s41598-019-48152-x.
|
| 369 |
EGF-induced C/EBP participates in EMT by decreasing the expression of miR-203 in esophageal squamous cell carcinoma cells.J Cell Sci. 2014 Sep 1;127(Pt 17):3735-44. doi: 10.1242/jcs.148759. Epub 2014 Jul 2.
|
| 370 |
SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.J Biomed Sci. 2019 Feb 18;26(1):20. doi: 10.1186/s12929-019-0510-4.
|
| 371 |
lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.Oncol Rep. 2016 Nov;36(5):2960-2966. doi: 10.3892/or.2016.5121. Epub 2016 Sep 22.
|
| 372 |
Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.Clin Cancer Res. 2011 Jan 1;17(1):46-55. doi: 10.1158/1078-0432.CCR-10-1155. Epub 2010 Nov 17.
|
| 373 |
A novel tumor suppressor SPINK5 targets Wnt/-catenin signaling pathway in esophageal cancer.Cancer Med. 2019 May;8(5):2360-2371. doi: 10.1002/cam4.2078. Epub 2019 Mar 13.
|
| 374 |
ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA.World J Gastroenterol. 2017 Mar 14;23(10):1796-1803. doi: 10.3748/wjg.v23.i10.1796.
|
| 375 |
EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.Target Oncol. 2014 Mar;9(1):43-52. doi: 10.1007/s11523-013-0260-2. Epub 2013 Feb 2.
|
| 376 |
LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.J Thorac Cardiovasc Surg. 2018 Apr;155(4):1891-1899. doi: 10.1016/j.jtcvs.2017.11.067. Epub 2017 Dec 23.
|
| 377 |
Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.Cancer Res. 2008 Feb 15;68(4):1074-82. doi: 10.1158/0008-5472.CAN-07-0964.
|
| 378 |
Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer.J Thorac Dis. 2017 Nov;9(11):4461-4476. doi: 10.21037/jtd.2017.10.60.
|
| 379 |
NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.Cancer Biol Ther. 2016 Sep;17(9):943-54. doi: 10.1080/15384047.2016.1210734. Epub 2016 Jul 14.
|
| 380 |
TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.Oncotarget. 2017 Mar 21;8(12):19274-19284. doi: 10.18632/oncotarget.13866.
|
| 381 |
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.Oncogene. 2005 Jun 9;24(25):4138-48. doi: 10.1038/sj.onc.1208598.
|
| 382 |
Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.Oncotarget. 2017 Jul 25;8(41):70035-70048. doi: 10.18632/oncotarget.19550. eCollection 2017 Sep 19.
|
| 383 |
Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.
|
| 384 |
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.Cancer Sci. 2018 Oct;109(10):3080-3092. doi: 10.1111/cas.13762. Epub 2018 Aug 28.
|
| 385 |
TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLC.Oncol Rep. 2019 Apr;41(4):2117-2125. doi: 10.3892/or.2019.6989. Epub 2019 Jan 30.
|
| 386 |
Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.Neoplasia. 2003 Mar-Apr;5(2):121-7. doi: 10.1016/s1476-5586(03)80003-9.
|
| 387 |
Cisplatin induces fas expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells.Oncology. 2000 Nov;59(4):336-43. doi: 10.1159/000012192.
|
| 388 |
Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.Am J Surg. 2007 Sep;194(3):380-4. doi: 10.1016/j.amjsurg.2007.01.026.
|
| 389 |
Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer.Carcinogenesis. 2002 Oct;23(10):1695-9. doi: 10.1093/carcin/23.10.1695.
|
| 390 |
Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.World J Gastroenterol. 2006 Oct 7;12(37):6041-5. doi: 10.3748/wjg.v12.i37.6041.
|
| 391 |
Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray.World J Gastroenterol. 2003 Mar;9(3):392-8. doi: 10.3748/wjg.v9.i3.392.
|
| 392 |
Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis.Biochem Biophys Res Commun. 1997 Dec 18;241(2):481-5. doi: 10.1006/bbrc.1997.7818.
|
| 393 |
Serological identification of tumor antigens of esophageal squamous cell carcinoma.Int J Oncol. 2005 Jan;26(1):77-86.
|
| 394 |
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.J Chemother. 2006 Oct;18(5):514-24. doi: 10.1179/joc.2006.18.5.514.
|
| 395 |
Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation.Lab Invest. 2004 Oct;84(10):1289-304. doi: 10.1038/labinvest.3700159.
|
| 396 |
Down-regulation in human cancers of DRHC, a novel helicase-like gene from 17q25.1 that inhibits cell growth.Cancer Lett. 2003 Apr 10;193(1):41-7. doi: 10.1016/s0304383502006882.
|
| 397 |
Negative implication of C-MYC as an amplification target in esophageal cancer.Cancer Genet Cytogenet. 2006 Feb;165(1):20-4. doi: 10.1016/j.cancergencyto.2005.07.009.
|
| 398 |
Molecular cloning and characterization of OSR1 on human chromosome 2p24.Int J Mol Med. 2002 Aug;10(2):221-5.
|
| 399 |
Polo-like kinase and survivin are esophageal tumor-specific promoters.Biochem Biophys Res Commun. 2006 Apr 7;342(2):465-71. doi: 10.1016/j.bbrc.2006.01.177. Epub 2006 Feb 9.
|
| 400 |
Hypermethylation of the GATA gene family in esophageal cancer.Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092.
|
| 401 |
Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.Pathol Int. 2007 Oct;57(10):672-80. doi: 10.1111/j.1440-1827.2007.02156.x.
|
| 402 |
Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.Mol Cell Biol. 2007 Sep;27(17):6068-83. doi: 10.1128/MCB.00664-07. Epub 2007 Jun 25.
|
| 403 |
Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.Oncol Res. 2017 Aug 7;25(7):1061-1068. doi: 10.3727/096504016X14830466773541. Epub 2017 Jan 20.
|
| 404 |
No association of single nucleotide polymorphisms involved in GHRL and GHSR with cancer risk: a meta-analysis.Cancer Biomark. 2015;15(1):89-97. doi: 10.3233/CBM-140441.
|
| 405 |
Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.World J Gastroenterol. 2006 Nov 28;12(44):7104-12. doi: 10.3748/wjg.v12.i44.7104.
|
|
|
|
|
|
|
